A Family of Dicopper(I) Complexes
Inorganic Chemistry, Vol. 39, No. 23, 2000 5227
7.14-7.40 (m, 22 H), 7.46 (d, J ) 7 Hz, 2 H), 7.63 (d, J ) 7 Hz, 2
H), 7.66-7.80 (m, 2 H), 8.11 (d, J ) 7 Hz, 2 H), 8.80 (d, J ) 4 Hz,
4 H). FTIR (KBr, cm-1): 3072 (m), 3029 (w), 2929 (w), 2862 (w),
2839 (w), 1666 (s), 1519 (m), 1498 (m), 1488 (m), 1449 (s), 1436
(m), 1353 (w), 1282 (s), 1222 (m), 1153 (s), 1069 (w), 1029 (s), 971
(m), 879 (m), 856 (m), 788 (m), 755 (s), 700 (s), 630(s). Anal. Calcd
for 2, C50H46N6O6S2F6Cu2: C, 53.04; H, 4.10; N, 7.42. Found: C, 52.93;
H, 3.91; N, 7.24.
(µ-O2CCPh3)](OTf) (5), where py ) pyridine, 1-Me-Im )
1-methylimidazole, and 1-Me-BzIm ) 1-methylbenzimidazole,
were prepared and their chemical and electrochemical oxida-
tions investigated. A mixed-valence complex [Cu2(BBAN)-
(µ-O2CCPh3)(OTf)](OTf) (6) was obtained when complex 5 was
treated with 1 equiv of silver(I) triflate. The physical properties
of complex 6 were studied and compared with those of previous
compounds.
[Cu2(BBAN)(1-Me-BzIm)2](OTf)2 (3). A portion of BBAN (30 mg,
0.055 mmol) in THF (0.5 mL) was added to a solution of [Cu(CH3-
CN)4](OTf) (41.2 mg, 0.11 mmol) in THF (1 mL). The color of the
solution turned to pink. A portion of 1-methylbenzimidazole (14.4 mg,
0.11 mmol) was added, and the solution turned yellow. After 30 min
of stirring, the solvent was removed under vacuum. The residue was
dissolved in CH2Cl2. Purple blocks suitable for X-ray crystallography
were obtained by vapor diffusion of Et2O into the CH2Cl2 solution.
The product became a blue powder after collection and drying under
Experimental Section
General Procedures and Methods. All reagents were obtained from
commercial suppliers and used without further purification unless
otherwise noted. THF was distilled from sodium benzophenone ketyl
under nitrogen. Pentane and Et2O were purified by passing through
activated Al2O3 columns under nitrogen. Dichloromethane was distilled
from CaH2 under nitrogen. Fourier transform infrared spectra were
recorded on a Bio-Rad FTS135 instrument. UV-vis spectra were
recorded on a Varian 1-E spectrophotometer. The ligand BBAN was
synthesized according to procedures reported elsewhere.22 [Cu(CH3-
CN)4](OTf) was prepared by following a known procedure.23 All air-
sensitive manipulations were carried out either in a nitrogen-filled
Vacuum Atmospheres drybox or by standard Schlenk line techniques.
Electrochemistry. Cyclic voltammetric measurements were per-
formed in a Vacuum Atmospheres drybox under N2 with an EG&G
model 263 potentiostat. A three-electrode configuration consisting of
a 1.75 mm2 platinum working electrode, a Ag/AgNO3 (0.1 M in CH3-
CN) reference electrode, and a coiled platinum wire auxiliary electrode
was used. The supporting electrolyte was 0.5 M (Bu4N)(PF6). Sample
concentrations of 2 mM were used for typical experiments. Scan rate
profiles were conducted for each sample, at scan speeds of 25-150
mV/s, and compared to that obtained for Cp2Fe under identical
conditions. All cyclic voltammograms were externally referenced to
Cp2Fe.
1
vacuum (32 mg, 47%). H NMR (CDCl3, 300 MHz): δ 3.54-4.00
(m, broad, 14 H), 4.45 (s, broad, 4 H), 7.08 ∼ 7.46 (m, 24 H), 7.63 (d,
J ) 8 Hz, 2 H), 7.89 (d, J ) 7.8 Hz, 2 H), 8.11 (d, J ) 7 Hz, 2 H),
8.92 (s, 2 H). FTIR (KBr, cm-1): 3110 (m), 3087 (w), 3062 (m), 3030
(m), 2927 (w), 2891 (w), 2853 (m), 1607 (s), 1523 (s), 1477 (w), 1459
(s), 1369 (m), 1277 (s), 1224 (m), 1153 (s), 1070 (w), 1030 (s), 974
(w), 877 (w), 856 (w), 747 (s), 703 (s), 638 (s). Anal. Calcd for 3,
C56H52N8O6S2F6Cu2: C, 54.32; H, 4.23; N, 9.05. Found: C, 54.02; H,
4.33; N, 8.96.
[Cu2(BBAN)(1-Me-Im)2](OTf)2 (4). A portion of BBAN (20 mg,
0.036 mmol) in THF (0.5 mL) was added to a solution of [Cu(CH3-
CN)4](OTf) (27.5 mg, 0.073 mmol) in THF (1 mL). The color of the
solution turned to pink. A portion of 1-methylimidazole (5.8 µL, 0.073
mmol) was added, and the solution turned yellow. After 30 min of
stirring, the solvent was removed under vacuum. The residue was
dissolved in CH2Cl2. Layering Et2O on top of the CH2Cl2 solution for
1 week yielded green blocks suitable for X-ray crystallography (19
1
mg, 46%). H NMR (CDCl3, 300 MHz): δ 3.78 (s, 8 H), 3.84 (s, 6
EPR Spectroscopy. The EPR spectrum was collected as frozen
2-methyltetrahydrofuran glass on a Bruker model 300 ESP X-band
spectrometer operating at 9.37 GHz and running WinEPR software.
Low temperature was maintained at 77 K with a specially designed
coldfinger filled with liquid N2 and at liquid-helium temperature with
an Oxford Instruments EPR 900 crystat. Simulation was carried out
with the WINEPR SimFonia program package.24 Simultaneous coupling
of the unpaired spin to two I ) 3/2 copper centers was incorporated
into the fit.
H), 4.24 (s, 4 H), 6.90-6.98 (broad, 2 H), 7.08-7.48 (m, broad, 20
H), 7.56-7.72 (m, broad, 4 H), 8.23 (broad, 2 H), 8.37 (d, J ) 7 Hz,
2 H). FTIR (KBr, cm-1): 3136 (m), 3126 (w), 3132 (w), 3062 (w),
2962 (w), 2843 (w), 1608 (s), 1541 (m), 1522 (m), 1497 (w), 1458
(m), 1427 (m), 1368 (w), 1264 (m), 1224 (m), 1160 (s), 1114 (m),
1099 (w), 1029 (s), 970 (w), 857 (w), 819 (w), 791 (w), 749 (s), 703
(m), 657 (m), 638 (s). Anal. Calcd for 4, C52H40N8O6S2F6Cu2: C, 50.65;
H, 4.25; N, 9.85. Found: C, 50.27; H, 4.10; N, 9.77.
[Cu2(BBAN)(µ-O2CCPh3)](OTf) (5). A portion of BBAN (20 mg,
0.036 mmol) in THF (0.5 mL) was added to a solution of [Cu(CH3-
CN)4](OTf) (27.5 mg, 0.073 mmol) in THF (1 mL). The solution turned
pink, and a solution of sodium triphenylacetate (11.3 mg, 0.036 mmol)
in THF (0.5 mL) was added. The color of the solution turned to green.
After 30 min of stirring, the solvent was removed under vacuum. Green
plates suitable for X-ray crystallography were obtained from pentane/
[Cu2(BBAN)(CH3CN)2](OTf)2 (1). A portion of BBAN (50 mg,
0.091 mmol) in THF (0.5 mL) was added to a solution of [Cu(CH3-
CN)4](OTf) (68.7 mg, 0.182 mmol) in THF (1 mL). The solution turned
pink, and the product began to precipitate. After 1 h of stirring, the
pink product was isolated and dried under vacuum (80.5 mg, 84%).
Single crystals suitable for X-ray crystallographic study were obtained
1
by diffusion of Et2O into a saturated CH2Cl2 solution at -30 °C. H
1
Et2O/benzene (27 mg, 67%). H NMR (CDCl3, 300 MHz): δ 3.70-
NMR (CDCl3, 300 MHz): δ 2.17 (s, 6 H), 4.13 (s, 8 H), 4.22 (s, 4 H),
7.10-7.26 (m, 12 H), 7.32-7.50 (m, 8 H), 7.62 (broad, 2 H), 8.26 (d,
J ) 8 Hz, 2 H). FTIR (KBr, cm-1): 3085 (w), 3064 (w), 3032 (w),
2932 (w), 2859 (w), 2290 (w), 1610 (m), 1560 (w), 1264 (s), 1226
(m), 1152 (s), 1032 (s), 877 (w), 852 (w), 791 (w), 754 (m), 706 (m),
638 (s). Anal. Calcd for 1, C44H42N6O6S2F6Cu2: C, 50.04; H, 4.01; N,
7.96. Found: C, 49.86; H, 4.20; N, 7.81.
4.30 (m, broad, 12 H), 7.00-7.46 (m, 29 H), 7.58-7.70 (m, 6 H),
8.40 (broad, 2 H), 8.57 (broad, 2 H), 7.62 (broad, 2 H), 8.26 (d, J )
8 Hz, 2 H). FTIR (KBr, cm-1): 3080 (m), 3032 (m), 2920 (m), 2848
(w), 1617 (s), 1606 (s), 1551 (s), 1494 (m), 1479 (s), 1448 (m), 1380
(s), 1274 (s), 1268 (s), 1224 (w), 1161 (s), 1149 (s), 1031 (s), 998 (s),
873 (s), 755 (s), 743 (s), 701 (s), 638 (s). UV-vis (THF, λmax, nm (ꢀ,
M-1 cm-1)): 640 (96). Anal. Calcd for 5, C59H51N4O5SF3Cu2: C, 63.71;
H, 4.62; N, 5.04. Found: C, 63.59; H, 4.45; N, 4.96.
[Cu2(BBAN)(py)2](OTf)2 (2). A portion of BBAN (50 mg, 0.091
mmol) in THF (0.5 mL) was added to a solution of [Cu(CH3CN)4]-
(OTf) (68.7 mg, 0.182 mmol) in THF (1 mL). The color of the solution
turned to pink. A portion of pyridine (15 µL, 0.182 mmol) was added,
and the solution turned yellow. After 30 min of stirring, the solvent
was removed under vacuum. The residue was dissolved in CH2Cl2.
Crystallization by vapor diffusion of Et2O into this CH2Cl2 solution
yielded green-brown blocks suitable for X-ray crystallography (78 mg,
[Cu2(BBAN)(µ-O2CCPh3)(OTf)](OTf) (6). A portion of BBAN (20
mg, 0.036 mmol) in THF (0.5 mL) was added to a solution of [Cu-
(CH3CN)4](OTf) (27.5 mg, 0.073 mmol) in THF (1 mL). The solution
turned pink, and a solution of sodium triphenylacetate (11.3 mg, 0.036
mmol) in THF (0.5 mL) was added. The color of the solution turned
to yellow. After 30 min of stirring, a solution of AgOTf (9.4 mg, 0.036
mmol) in THF (0.5 mL) was added. The mixture was allowed to stir
for 5 h. Solvent was removed under vacuum. The residue was extracted
with CH2Cl2 and filtered. Deep purple plates suitable for X-ray
crystallography were obtained from pentane/Et2O/CH2Cl2 (11 mg, 24%).
FTIR (KBr, cm-1): 3085 (w), 3065 (m), 3031 (w), 2940 (w), 2920
(w), 2871 (w), 1616 (s), 1604 (m), 1541 (m), 1496 (m), 1458 (m),
1
76%). H NMR (CDCl3, 300 MHz): δ 3.76 (s, 8 H), 4.43 (s, 4 H),
(22) He, C.; Lippard, S. J. Tetrahedron 2000, 56, 8245-8252.
(23) Kubas, G. J. Inorg. Synth. 1979, 19, 90-92.
(24) WINEPR-SimFonia, 1.25; Bruker Analytik GmbH: Karlsruhe, FRG,
1994-1996.